JAMES N WILSON
CIK 1236387 · last filed 2026-05-29
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$16.58M
Companies
2
Total Filings
83
Lifetime Open-Market Net
-$3.82M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CORT | Director | 200,000 | $82.91 | $16.58M | -$3.16M | 67 | 2026-05-29 |
| AMYLIN PHARMACEUTICALS INC (AMLN) Delisted | Director | 2,000 | — | — | -$658.8K | 16 | 2009-04-07 |
Recent Filings · Page 9 of 9
83 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2007-04-03 | CORT | Buy (P) | +360,000 | $360.0K | EDGAR |
| 2007-03-02 | AMYLIN PHARMACEUTICALS INC (AMLN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-01-17 | AMYLIN PHARMACEUTICALS INC (AMLN) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 81–83 of 83
Prev
Page 9 of 9
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.